https://www.drarsy.com/fr/blogs/news/der-p1-der-p2-patch-36-eczema-allergy-vs-irritancy-study 2026-11-10T18:51:55-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/mite-29.jpg?v=1794365515 https://www.drarsy.com/fr/blogs/news/lip-eczema-cinnamon-flavor-gum-tea-contact-reaction 2026-11-11T00:28:06-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/exec-4b1b2080-cccc-489f-8cc2-c36d421d2fcb.png?v=1794368667 https://www.drarsy.com/fr/blogs/news/occupational-contact-urticaria-815-finnish-cases 2026-11-10T19:54:20-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-01-finnish_ocu_815.png?v=1794369260 https://www.drarsy.com/fr/blogs/news/eczema-itch-lesion-phenotypes-4433-us-costs-study 2026-11-11T00:26:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-01.jpg?v=1794369262 https://www.drarsy.com/fr/blogs/news/latex-sensitization-1171-healthcare-other-workers 2026-11-11T00:26:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-02-latex_1171.png?v=1794369263 https://www.drarsy.com/fr/blogs/news/occupational-contact-urticaria-143-1720-australian-patients 2026-11-10T19:54:26-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-03-australian_ocu_143.png?v=1794369266 https://www.drarsy.com/fr/blogs/news/contact-dermatitis-432-north-american-hairdressers-cosmetologists 2026-11-10T19:54:29-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-04-hairdressers_432.png?v=1794369269 https://www.drarsy.com/fr/blogs/news/hand-eczema-career-change-5324-danish-hairdressers 2026-11-10T19:54:32-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-06-hair_career_5324.png?v=1794369272 https://www.drarsy.com/fr/blogs/news/contact-dermatitis-87-car-repair-workers-76-controls 2026-11-11T00:26:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-05-car_repair_87.png?v=1794369275 https://www.drarsy.com/fr/blogs/news/adult-eczema-us-healthcare-costs-severity-linked-emr-claims 2026-11-11T00:26:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-02.jpg?v=1794369277 https://www.drarsy.com/fr/blogs/news/adult-eczema-direct-indirect-costs-31164-matched-study 2026-11-11T00:26:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-03.jpg?v=1794369278 https://www.drarsy.com/fr/blogs/news/employment-sick-leave-8940-occupational-dermatitis-notifications 2026-11-10T19:54:38-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-07-employment_8940.png?v=1794369278 https://www.drarsy.com/fr/blogs/news/child-eczema-caregiver-out-of-pocket-costs-1118-survey 2026-11-11T00:26:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-06.jpg?v=1794369280 https://www.drarsy.com/fr/blogs/news/six-month-work-outcomes-78-workers-contact-dermatitis 2026-11-11T00:26:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-08-rtw_78.png?v=1794369281 https://www.drarsy.com/fr/blogs/news/child-eczema-under-six-23098-us-healthcare-costs 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-05.jpg?v=1794369281 https://www.drarsy.com/fr/blogs/news/adult-eczema-119716-us-commercial-medicare-medicaid-costs 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-04.jpg?v=1794369283 https://www.drarsy.com/fr/blogs/news/testing-hand-dermatitis-questionnaire-224-rubber-workers 2026-11-10T19:54:45-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-10-rubber_questionnaire_224.png?v=1794369285 https://www.drarsy.com/fr/blogs/news/child-eczema-financial-emotional-impact-82-family-study 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-07.jpg?v=1794369286 https://www.drarsy.com/fr/blogs/news/return-to-work-outcomes-194-occupational-dermatitis-patients 2026-11-10T19:54:48-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-09-rtw_clinic_194.png?v=1794369288 https://www.drarsy.com/fr/blogs/news/child-eczema-cost-illness-multiethnic-asian-study 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-08.jpg?v=1794369288 https://www.drarsy.com/fr/blogs/news/allergic-disease-head-registry-778-europe-economic-impact 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-10.jpg?v=1794369289 https://www.drarsy.com/fr/blogs/news/moderate-severe-eczema-europe-costs-societal-review 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-09.jpg?v=1794369291 https://www.drarsy.com/fr/blogs/news/contact-sensitization-3356-german-metalworkers 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-11-metalworkers_3356.png?v=1794369291 https://www.drarsy.com/fr/blogs/news/adult-adolescent-eczema-burden-233-study-systematic-review 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-11.jpg?v=1794369292 https://www.drarsy.com/fr/blogs/news/contact-urticaria-three-large-clinical-cohorts 2026-11-10T19:54:54-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-12-cu_three_cohorts.png?v=1794369294 https://www.drarsy.com/fr/blogs/news/eczema-economic-impact-us-five-billion-review 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-12.jpg?v=1794369296 https://www.drarsy.com/fr/blogs/news/adult-eczema-nhis-cost-access-workdays-61770-study 2026-11-11T00:26:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-15.jpg?v=1794369297 https://www.drarsy.com/fr/blogs/news/occupational-contact-urticaria-trends-251-french-cases 2026-11-10T19:54:57-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-13-french_ocu_251.png?v=1794369297 https://www.drarsy.com/fr/blogs/news/eczema-harmful-household-financial-impact-1118-us-survey 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-14.jpg?v=1794369299 https://www.drarsy.com/fr/blogs/news/eczema-out-of-pocket-expenses-1118-us-survey 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-13.jpg?v=1794369300 https://www.drarsy.com/fr/blogs/news/three-year-latex-follow-up-1040-healthcare-workers 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-14-powder_free_1040.png?v=1794369300 https://www.drarsy.com/fr/blogs/news/child-eczema-quality-life-healthcare-costs-cross-sectional 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-16.jpg?v=1794369302 https://www.drarsy.com/fr/blogs/news/work-ability-latex-exposure-controls-196-healthcare-workers 2026-11-10T19:55:03-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-15-latex_work_196.png?v=1794369303 https://www.drarsy.com/fr/blogs/news/adult-eczema-unmet-needs-work-daily-life-186-survey 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-17.jpg?v=1794369305 https://www.drarsy.com/fr/blogs/news/occupational-skin-disease-surveillance-336-saarland-cases 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-17-saarland_336.png?v=1794369306 https://www.drarsy.com/fr/blogs/news/eczema-out-of-pocket-costs-nine-european-countries-1189 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-18.jpg?v=1794369307 https://www.drarsy.com/fr/blogs/news/adult-eczema-france-out-of-pocket-costs-1024-cohort 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-19.jpg?v=1794369308 https://www.drarsy.com/fr/blogs/news/twelve-years-occupational-skin-disease-5265-finnish-cases 2026-11-10T19:55:09-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-16-finland_registry_5265.png?v=1794369309 https://www.drarsy.com/fr/blogs/news/child-mild-moderate-eczema-sweden-87721-economic-burden 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-20.jpg?v=1794369310 https://www.drarsy.com/fr/blogs/news/adult-eczema-germany-cost-illness-1291-routine-care 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-21.jpg?v=1794369311 https://www.drarsy.com/fr/blogs/news/long-term-work-outcomes-230-workers-occupational-skin-disease 2026-11-10T19:55:12-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-18-work_outcome_230.png?v=1794369312 https://www.drarsy.com/fr/blogs/news/eczema-spain-specialized-care-3036-patient-cost-study 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-22.jpg?v=1794369315 https://www.drarsy.com/fr/blogs/news/occupational-skin-disease-555-685-australian-healthcare-workers 2026-11-10T19:55:15-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-19-australian_hcw_685.png?v=1794369315 https://www.drarsy.com/fr/blogs/news/eczema-canada-burden-76-patient-cost-study 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-24.jpg?v=1794369316 https://www.drarsy.com/fr/blogs/news/adult-eczema-japan-cost-illness-web-survey 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-23.jpg?v=1794369318 https://www.drarsy.com/fr/blogs/news/healing-lifestyle-factors-1491-occupational-hand-eczema-patients 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-1759-20-prognosis_1491.png?v=1794369318 https://www.drarsy.com/fr/blogs/news/eczema-korea-healthcare-use-270008-national-claims-study 2026-11-11T00:26:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-26.jpg?v=1794369319 https://www.drarsy.com/fr/blogs/news/eczema-korea-economic-impact-32-patient-cost-analysis 2026-11-11T00:26:29-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-25.jpg?v=1794369321 https://www.drarsy.com/fr/blogs/news/mild-moderate-eczema-uk-propensity-cost-study 2026-11-11T00:26:29-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-27.jpg?v=1794369324 https://www.drarsy.com/fr/blogs/news/child-eczema-sweden-controlled-uncontrolled-costs 2026-11-11T00:26:29-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-29.jpg?v=1794369325 https://www.drarsy.com/fr/blogs/news/adult-moderate-severe-eczema-denmark-societal-costs-5245 2026-11-11T00:26:29-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-28.jpg?v=1794369327 https://www.drarsy.com/fr/blogs/news/pediatric-eczema-economic-humanistic-burden-101-patient-study 2026-11-11T00:26:29-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-eczema-economic-burden-30.jpg?v=1794369329 https://www.drarsy.com/fr/blogs/news/child-facial-eczema-hydrocortisone-cream-safety-questions 2026-11-11T00:28:06-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/exec-a3e28b14-0724-4639-9e79-030e4b9e4793.png?v=1794371938 https://www.drarsy.com/fr/blogs/news/pediatric-tacrolimus-180-child-vehicle-dose-trial 2026-11-10T21:14:16-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pediatric-tacrolimus-180-child-vehicle-dose-trial.jpg?v=1794374055 https://www.drarsy.com/fr/blogs/news/tacrolimus-mild-moderate-eczema-617-adult-child-trials 2026-11-10T21:14:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/tacrolimus-mild-moderate-eczema-617-adult-child-trials.jpg?v=1794374068 https://www.drarsy.com/fr/blogs/news/adult-tacrolimus-steroid-regimen-972-six-month-trial 2026-11-10T21:14:31-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/adult-tacrolimus-steroid-regimen-972-six-month-trial.jpg?v=1794374071 https://www.drarsy.com/fr/blogs/news/adult-tacrolimus-steroid-regimen-80-one-year-trial 2026-11-10T21:14:34-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/adult-tacrolimus-steroid-regimen-80-one-year-trial.jpg?v=1794374074 https://www.drarsy.com/fr/blogs/news/pimecrolimus-tacrolimus-141-child-tolerability-trial 2026-11-10T21:14:37-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pimecrolimus-tacrolimus-141-child-tolerability-trial.jpg?v=1794374077 https://www.drarsy.com/fr/blogs/news/pimecrolimus-713-child-one-year-flare-prevention-trial 2026-11-10T21:14:40-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pimecrolimus-713-child-one-year-flare-prevention-trial.jpg?v=1794374080 https://www.drarsy.com/fr/blogs/news/adult-tacrolimus-632-vehicle-controlled-efficacy-trials 2026-11-10T21:14:43-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/adult-tacrolimus-632-vehicle-controlled-efficacy-trials.jpg?v=1794374083 https://www.drarsy.com/fr/blogs/news/child-tacrolimus-hydrocortisone-560-randomized-trial 2026-11-10T21:14:46-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/child-tacrolimus-hydrocortisone-560-randomized-trial.jpg?v=1794374086 https://www.drarsy.com/fr/blogs/news/adult-pimecrolimus-192-six-month-flare-prevention-study 2026-11-10T21:14:49-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/adult-pimecrolimus-192-six-month-flare-prevention-study.jpg?v=1794374089 https://www.drarsy.com/fr/blogs/news/topical-eczema-treatments-219-trial-network-meta-analysis 2026-11-10T21:14:52-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/topical-eczema-treatments-219-trial-network-meta-analysis.jpg?v=1794374091 https://www.drarsy.com/fr/blogs/news/infant-pimecrolimus-186-vehicle-controlled-trial 2026-11-10T21:14:55-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/infant-pimecrolimus-186-vehicle-controlled-trial.jpg?v=1794374095 https://www.drarsy.com/fr/blogs/news/child-pimecrolimus-403-two-vehicle-controlled-trials 2026-11-10T21:15:04-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/child-pimecrolimus-403-two-vehicle-controlled-trials.jpg?v=1794374104 https://www.drarsy.com/fr/blogs/news/pimecrolimus-961-infant-child-one-year-pooled-analysis 2026-11-10T21:15:07-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pimecrolimus-961-infant-child-one-year-pooled-analysis.jpg?v=1794374107 https://www.drarsy.com/fr/blogs/news/pimecrolimus-vehicle-13-trial-meta-analysis-4180 2026-11-10T21:15:10-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pimecrolimus-vehicle-13-trial-meta-analysis-4180.jpg?v=1794374110 https://www.drarsy.com/fr/blogs/news/pimecrolimus-sensitive-skin-27-trial-meta-analysis 2026-11-10T21:15:13-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pimecrolimus-sensitive-skin-27-trial-meta-analysis.jpg?v=1794374113 https://www.drarsy.com/fr/blogs/news/tacrolimus-7923-adult-child-open-label-study 2026-11-10T21:15:16-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/tacrolimus-7923-adult-child-open-label-study.jpg?v=1794374116 https://www.drarsy.com/fr/blogs/news/tacrolimus-canada-240-six-month-open-label-study 2026-11-10T21:15:19-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/tacrolimus-canada-240-six-month-open-label-study.jpg?v=1794374118 https://www.drarsy.com/fr/blogs/news/tacrolimus-quality-life-985-adult-child-trial-analysis 2026-11-10T21:15:21-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/tacrolimus-quality-life-985-adult-child-trial-analysis.jpg?v=1794374121 https://www.drarsy.com/fr/blogs/news/child-tacrolimus-fluticasone-479-noninferiority-trial 2026-11-10T21:15:24-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/child-tacrolimus-fluticasone-479-noninferiority-trial.jpg?v=1794374124 https://www.drarsy.com/fr/blogs/news/child-tacrolimus-466-long-term-safety-study 2026-11-10T21:15:27-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/child-tacrolimus-466-long-term-safety-study.jpg?v=1794374127 https://www.drarsy.com/fr/blogs/news/tacrolimus-pharmacokinetics-adult-child-12-trial-analysis 2026-11-10T21:15:30-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/tacrolimus-pharmacokinetics-adult-child-12-trial-analysis.jpg?v=1794374130 https://www.drarsy.com/fr/blogs/news/child-tacrolimus-pharmacokinetics-39-person-study 2026-11-10T21:15:40-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/child-tacrolimus-pharmacokinetics-39-person-study.jpg?v=1794374140 https://www.drarsy.com/fr/blogs/news/adult-tacrolimus-skin-blood-pharmacokinetics-14-study 2026-11-10T21:15:42-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/adult-tacrolimus-skin-blood-pharmacokinetics-14-study.jpg?v=1794374142 https://www.drarsy.com/fr/blogs/news/infant-tacrolimus-pharmacokinetics-53-once-twice-daily-study 2026-11-10T21:15:46-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/infant-tacrolimus-pharmacokinetics-53-once-twice-daily-study.jpg?v=1794374146 https://www.drarsy.com/fr/blogs/news/pimecrolimus-tacrolimus-pharmacokinetics-37-adult-comparison 2026-11-10T21:15:49-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pimecrolimus-tacrolimus-pharmacokinetics-37-adult-comparison.jpg?v=1794374148 https://www.drarsy.com/fr/blogs/news/infant-pimecrolimus-absorption-22-person-study 2026-11-10T21:15:52-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/infant-pimecrolimus-absorption-22-person-study.jpg?v=1794374152 https://www.drarsy.com/fr/blogs/news/eczema-lymphoma-topical-treatment-24-study-meta-analysis 2026-11-10T21:15:55-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/eczema-lymphoma-topical-treatment-24-study-meta-analysis.jpg?v=1794374155 https://www.drarsy.com/fr/blogs/news/tacrolimus-cutaneous-infections-1554-patient-analysis 2026-11-10T21:15:58-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/tacrolimus-cutaneous-infections-1554-patient-analysis.jpg?v=1794374157 https://www.drarsy.com/fr/blogs/news/tacrolimus-meningococcal-vaccine-response-232-child-trial 2026-11-10T21:16:00-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/tacrolimus-meningococcal-vaccine-response-232-child-trial.jpg?v=1794374160 https://www.drarsy.com/fr/blogs/news/tacrolimus-cancer-incidence-7954-child-apples-cohort 2026-11-10T21:16:03-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/tacrolimus-cancer-incidence-7954-child-apples-cohort.jpg?v=1794374163 https://www.drarsy.com/fr/blogs/news/occupational-contact-dermatitis-1255-healthcare-workers-15896-patients 2026-11-10T21:43:56-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-01-hcw_nacdg_1255.png?v=1794375835 https://www.drarsy.com/fr/blogs/news/skin-disease-4000-workers-104-greek-enterprises 2026-11-10T21:43:59-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-05-greek_enterprises_4000.png?v=1794375839 https://www.drarsy.com/fr/blogs/news/occupational-skin-disease-incidence-uk-specialists-2002-2005 2026-11-10T21:44:01-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-03-thor_2002_2005.png?v=1794375841 https://www.drarsy.com/fr/blogs/news/dermatitis-patch-tests-21-300-polyurethane-foam-workers 2026-11-10T21:44:04-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-04-polyurethane_foam_300.png?v=1794375844 https://www.drarsy.com/fr/blogs/news/skin-airway-allergy-2413-finnish-occupational-disease-cases 2026-11-10T21:44:07-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-02-frod_skin_airway_2413.png?v=1794375847 https://www.drarsy.com/fr/blogs/news/examining-757-finnish-machinists-occupational-dermatoses 2026-11-10T21:44:10-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-06-finnish_machinists_961.png?v=1794375850 https://www.drarsy.com/fr/blogs/news/mci-mi-dermatitis-outbreak-8-15-water-bottle-workers 2026-11-10T21:44:13-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-09-water_bottle_mci_15.png?v=1794375853 https://www.drarsy.com/fr/blogs/news/five-years-uk-occupational-skin-disease-reports 2026-11-10T21:44:16-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-07-uk_epiderm_opra_1996_2001.png?v=1794375856 https://www.drarsy.com/fr/blogs/news/six-years-epiderm-opra-occupational-skin-surveillance 2026-11-10T21:44:19-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-08-epiderm_opra_six_years.png?v=1794375859 https://www.drarsy.com/fr/blogs/news/smartphone-glue-dermatitis-13-screen-protector-workers 2026-11-10T21:44:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-10-screen_glue_13.png?v=1794375862 https://www.drarsy.com/fr/blogs/news/sealant-dermatitis-12-48-refrigerator-factory-workers 2026-11-10T21:44:25-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-11-sealant_48.png?v=1794375865 https://www.drarsy.com/fr/blogs/news/phenol-formaldehyde-dermatitis-two-plywood-mill-workers 2026-11-10T21:44:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-13-plywood_resin_2.png?v=1794375868 https://www.drarsy.com/fr/blogs/news/isocyanate-allergy-investigation-seven-heat-exchanger-workers 2026-11-10T21:44:30-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-12-isocyanate_heat_exchanger_7.png?v=1794375870 https://www.drarsy.com/fr/blogs/news/training-gaps-100-workers-hand-dermatitis 2026-11-10T21:44:33-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-15-training_hand_dermatitis_100.png?v=1794375873 https://www.drarsy.com/fr/blogs/news/769-recognized-occupational-skin-cases-french-cleaning-work 2026-11-10T21:44:36-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-14-french_cleaning_769.png?v=1794375876 https://www.drarsy.com/fr/blogs/news/glove-allergy-16-operating-theatre-workers 2026-11-10T21:44:39-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-17-sterile_gloves_16.png?v=1794375879 https://www.drarsy.com/fr/blogs/news/concurrent-skin-respiratory-symptoms-204-referred-workers 2026-11-10T21:44:41-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-16-skin_respiratory_204.png?v=1794375881 https://www.drarsy.com/fr/blogs/news/epoxy-reaction-investigation-25-carbon-fibre-workers 2026-11-10T21:44:44-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-18-carbon_epoxy_25.png?v=1794375884 https://www.drarsy.com/fr/blogs/news/chromate-amine-allergy-24-precast-concrete-workers 2026-11-10T21:44:47-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-19-precast_concrete_24.png?v=1794375887 https://www.drarsy.com/fr/blogs/news/7445-washington-workers-compensation-skin-claims 2026-11-10T21:44:50-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-2059-20-washington_claims_7445.png?v=1794375890 https://www.drarsy.com/fr/blogs/news/slugging-facial-eczema-occlusive-moisturizer-safety 2026-11-11T00:28:06-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/exec-9e5c4ffc-0ad7-410b-ab50-623dafe99d73.png?v=1794375939 https://www.drarsy.com/fr/blogs/news/crisaborole-maximal-use-34-child-pharmacokinetic-study 2026-11-10T21:59:08-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-maximal-use-34-child-pharmacokinetic-study.jpg?v=1794376748 https://www.drarsy.com/fr/blogs/news/proactive-crisaborole-142-child-randomized-trial 2026-11-10T21:59:10-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/proactive-crisaborole-142-child-randomized-trial.jpg?v=1794376750 https://www.drarsy.com/fr/blogs/news/crisaborole-once-daily-270-patient-52-week-maintenance 2026-11-10T21:59:12-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-once-daily-270-patient-52-week-maintenance.jpg?v=1794376752 https://www.drarsy.com/fr/blogs/news/crisaborole-adult-biomarker-40-person-intrapatient-trial 2026-11-10T21:59:14-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-adult-biomarker-40-person-intrapatient-trial.jpg?v=1794376753 https://www.drarsy.com/fr/blogs/news/pediatric-topical-pde4-five-rct-1877-meta-analysis 2026-11-10T21:59:15-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pediatric-topical-pde4-five-rct-1877-meta-analysis.jpg?v=1794376755 https://www.drarsy.com/fr/blogs/news/thailand-crisaborole-90-child-real-world-study 2026-11-10T21:59:17-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/thailand-crisaborole-90-child-real-world-study.jpg?v=1794376757 https://www.drarsy.com/fr/blogs/news/crisaborole-517-patient-48-week-long-term-safety-study 2026-11-10T21:59:19-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-517-patient-48-week-long-term-safety-study.jpg?v=1794376759 https://www.drarsy.com/fr/blogs/news/crisaborole-topical-treatment-network-meta-analysis 2026-11-10T21:59:21-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-topical-treatment-network-meta-analysis.jpg?v=1794376761 https://www.drarsy.com/fr/blogs/news/difamilast-73-child-phase2-dose-ranging-trial 2026-11-10T21:59:23-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/difamilast-73-child-phase2-dose-ranging-trial.jpg?v=1794376763 https://www.drarsy.com/fr/blogs/news/roflumilast-652-child-age2-5-integument-ped-trial 2026-11-10T21:59:25-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/roflumilast-652-child-age2-5-integument-ped-trial.jpg?v=1794376765 https://www.drarsy.com/fr/blogs/news/crisaborole-137-infant-crisade-care1-study 2026-11-10T21:59:27-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-137-infant-crisade-care1-study.jpg?v=1794376767 https://www.drarsy.com/fr/blogs/news/topical-pde4-seven-study-1869-person-meta-analysis 2026-11-10T21:59:29-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/topical-pde4-seven-study-1869-person-meta-analysis.jpg?v=1794376769 https://www.drarsy.com/fr/blogs/news/difamilast-121-adult-adolescent-phase2-trial 2026-11-10T21:59:31-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/difamilast-121-adult-adolescent-phase2-trial.jpg?v=1794376770 https://www.drarsy.com/fr/blogs/news/crisaborole-pruritus-qol-mediation-analysis-1522 2026-11-10T21:59:32-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-pruritus-qol-mediation-analysis-1522.jpg?v=1794376772 https://www.drarsy.com/fr/blogs/news/crisaborole-quality-life-1522-phase3-pooled-study 2026-11-10T21:59:34-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-quality-life-1522-phase3-pooled-study.jpg?v=1794376774 https://www.drarsy.com/fr/blogs/news/crisaborole-pruritus-quality-life-1522-longitudinal-analysis 2026-11-10T21:59:36-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-pruritus-quality-life-1522-longitudinal-analysis.jpg?v=1794376776 https://www.drarsy.com/fr/blogs/news/crisaborole-adsi-body-surface-area-1522-pooled-analysis 2026-11-10T21:59:38-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-adsi-body-surface-area-1522-pooled-analysis.jpg?v=1794376778 https://www.drarsy.com/fr/blogs/news/crisaborole-application-site-pain-retrospective-study 2026-11-10T22:00:11-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-application-site-pain-retrospective-study.jpg?v=1794376811 https://www.drarsy.com/fr/blogs/news/israel-crisaborole-441-real-world-patient-study 2026-11-10T22:00:13-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/israel-crisaborole-441-real-world-patient-study.jpg?v=1794376813 https://www.drarsy.com/fr/blogs/news/crisaborole-contact-allergy-child-case-report 2026-11-10T22:00:15-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-contact-allergy-child-case-report.jpg?v=1794376815 https://www.drarsy.com/fr/blogs/news/difamilast-41-infant-52-week-open-label-study 2026-11-10T22:00:18-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/difamilast-41-infant-52-week-open-label-study.jpg?v=1794376817 https://www.drarsy.com/fr/blogs/news/crisaborole-pediatric-baseline-severity-pruritus-analysis 2026-11-10T22:00:20-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-pediatric-baseline-severity-pruritus-analysis.jpg?v=1794376820 https://www.drarsy.com/fr/blogs/news/crisaborole-1313-child-subgroup-analysis 2026-11-10T22:00:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-1313-child-subgroup-analysis.jpg?v=1794376821 https://www.drarsy.com/fr/blogs/news/crisaborole-systemic-exposure-244-person-regression-study 2026-11-10T22:00:24-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-systemic-exposure-244-person-regression-study.jpg?v=1794376824 https://www.drarsy.com/fr/blogs/news/pediatric-topical-eczema-medication-safety-75-study-review 2026-11-10T22:00:26-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pediatric-topical-eczema-medication-safety-75-study-review.jpg?v=1794376826 https://www.drarsy.com/fr/blogs/news/crisaborole-clinical-development-pde4-review 2026-11-10T22:00:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-clinical-development-pde4-review.jpg?v=1794376828 https://www.drarsy.com/fr/blogs/news/crisaborole-adult-phase2a-vehicle-controlled-proof-concept 2026-11-10T22:00:31-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-adult-phase2a-vehicle-controlled-proof-concept.jpg?v=1794376831 https://www.drarsy.com/fr/blogs/news/e6005-40-adult-dose-ranging-pde4-trial 2026-11-10T22:00:33-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/e6005-40-adult-dose-ranging-pde4-trial.jpg?v=1794376833 https://www.drarsy.com/fr/blogs/news/oral-apremilast-185-adult-eczema-phase2-trial 2026-11-10T22:00:35-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/oral-apremilast-185-adult-eczema-phase2-trial.jpg?v=1794376835 https://www.drarsy.com/fr/blogs/news/apremilast-cyclosporine-50-adult-randomized-study 2026-11-10T22:00:38-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/apremilast-cyclosporine-50-adult-randomized-study.jpg?v=1794376837 https://www.drarsy.com/fr/blogs/news/contact-dermatitis-8-17-paint-factory-workers-acticide-ep 2026-11-10T22:47:39-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-01.png?v=1794379659 https://www.drarsy.com/fr/blogs/news/isocyanate-lacquer-allergy-five-laminate-board-workers 2026-11-10T22:47:42-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-02.png?v=1794379662 https://www.drarsy.com/fr/blogs/news/particleboard-factory-dermatitis-investigation-new-process 2026-11-10T22:56:33-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-03.png?v=1794379665 https://www.drarsy.com/fr/blogs/news/occupational-dermatoses-603-epoxy-rotor-blade-workers 2026-11-10T22:47:48-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-07.png?v=1794379668 https://www.drarsy.com/fr/blogs/news/skin-disease-426-pesticide-authorized-farm-workers-100-controls 2026-11-10T22:47:51-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-06.png?v=1794379671 https://www.drarsy.com/fr/blogs/news/dibutyl-maleate-dermatitis-10-20-envelope-factory-workers 2026-11-10T22:47:54-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-09.png?v=1794379674 https://www.drarsy.com/fr/blogs/news/oil-acne-dermatitis-159-building-materials-workers 2026-11-10T22:47:57-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-08.png?v=1794379677 https://www.drarsy.com/fr/blogs/news/contact-dermatitis-ten-spanish-wind-energy-workers 2026-11-10T22:48:00-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-04.png?v=1794379680 https://www.drarsy.com/fr/blogs/news/skin-findings-341-south-indian-paddy-field-workers 2026-11-10T22:48:03-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-05.png?v=1794379683 https://www.drarsy.com/fr/blogs/news/skin-symptoms-70-spice-factory-workers-23-office-staff 2026-11-10T22:48:07-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-10.png?v=1794379686 https://www.drarsy.com/fr/blogs/news/uv-curing-resin-dermatitis-industrial-homeworker-case 2026-11-10T22:48:09-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-11.png?v=1794379689 https://www.drarsy.com/fr/blogs/news/kathon-occupational-dermatitis-milk-industry-worker 2026-11-10T22:48:12-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-12.png?v=1794379692 https://www.drarsy.com/fr/blogs/news/eptmac-hand-dermatitis-four-starch-process-workers 2026-11-10T22:48:16-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-13.png?v=1794379695 https://www.drarsy.com/fr/blogs/news/epoxy-dermatitis-eight-130-fiberglass-workers 2026-11-10T22:48:19-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-14.png?v=1794379698 https://www.drarsy.com/fr/blogs/news/facial-eczema-makeup-brushes-cleaning-sensitive-skin 2026-11-11T00:28:11-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/exec-f81f6c86-e0c1-4ca9-8026-6948d4bd672e.png?v=1794379701 https://www.drarsy.com/fr/blogs/news/occupational-dermatoses-binder-plant-83-current-12-former-workers 2026-11-10T22:48:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-17.png?v=1794379702 https://www.drarsy.com/fr/blogs/news/contact-dermatitis-45-semisynthetic-penicillin-factory-workers 2026-11-10T22:48:25-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-15.png?v=1794379704 https://www.drarsy.com/fr/blogs/news/occupational-colophonium-allergy-39-patients 2026-11-10T22:48:28-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-16.png?v=1794379708 https://www.drarsy.com/fr/blogs/news/methylisothiazolinone-contact-allergy-four-14-paint-workers 2026-11-10T22:48:31-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-18.png?v=1794379711 https://www.drarsy.com/fr/blogs/news/isocyanate-allergy-16-medical-equipment-factory-workers 2026-11-10T22:48:34-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-19.png?v=1794379714 https://www.drarsy.com/fr/blogs/news/resin-dermatitis-50-car-assembly-workers-weatherstrips 2026-11-10T22:48:37-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/dr-arsy-life-in-motion-20261110-2159-20.png?v=1794379717 https://www.drarsy.com/fr/blogs/news/ati1777-topical-jak1-3-48-adult-phase2a-trial 2026-11-10T23:05:38-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ati1777-topical-jak1-3-48-adult-phase2a-trial.jpg?v=1794380738 https://www.drarsy.com/fr/blogs/news/topical-tofacitinib-69-adult-phase2a-randomized-trial 2026-11-10T23:05:40-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/topical-tofacitinib-69-adult-phase2a-randomized-trial.jpg?v=1794380740 https://www.drarsy.com/fr/blogs/news/delgocitinib-children-2-15-phase2-dose-trial 2026-11-10T23:05:42-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/delgocitinib-children-2-15-phase2-dose-trial.jpg?v=1794380742 https://www.drarsy.com/fr/blogs/news/delgocitinib-adult-phase3-28-week-extension-study 2026-11-10T23:05:44-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/delgocitinib-adult-phase3-28-week-extension-study.jpg?v=1794380743 https://www.drarsy.com/fr/blogs/news/delgocitinib-pediatric-phase3-56-week-long-term-study 2026-11-10T23:05:45-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/delgocitinib-pediatric-phase3-56-week-long-term-study.jpg?v=1794380745 https://www.drarsy.com/fr/blogs/news/jte052-delgocitinib-phase1-phototoxicity-pk-study 2026-11-10T23:05:47-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/jte052-delgocitinib-phase1-phototoxicity-pk-study.jpg?v=1794380747 https://www.drarsy.com/fr/blogs/news/jte052-327-adult-dose-ranging-tacrolimus-reference-trial 2026-11-10T23:05:49-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/jte052-327-adult-dose-ranging-tacrolimus-reference-trial.jpg?v=1794380749 https://www.drarsy.com/fr/blogs/news/delgocitinib-506-adult-52-week-safety-study 2026-11-10T23:05:51-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/delgocitinib-506-adult-52-week-safety-study.jpg?v=1794380751 https://www.drarsy.com/fr/blogs/news/delgocitinib-22-infant-52-week-open-label-study 2026-11-10T23:05:53-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/delgocitinib-22-infant-52-week-open-label-study.jpg?v=1794380753 https://www.drarsy.com/fr/blogs/news/delgocitinib-pediatric-dose-severity-posthoc-analysis 2026-11-10T23:05:55-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/delgocitinib-pediatric-dose-severity-posthoc-analysis.jpg?v=1794380755 https://www.drarsy.com/fr/blogs/news/ruxolitinib-cream-adolescents-pooled-52-week-analysis 2026-11-10T23:06:05-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-cream-adolescents-pooled-52-week-analysis.jpg?v=1794380765 https://www.drarsy.com/fr/blogs/news/ruxolitinib-cream-1208-patient-reported-outcomes-analysis 2026-11-10T23:06:08-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-cream-1208-patient-reported-outcomes-analysis.jpg?v=1794380768 https://www.drarsy.com/fr/blogs/news/ruxolitinib-103-adolescent-one-year-open-label-study 2026-11-10T23:06:10-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-103-adolescent-one-year-open-label-study.jpg?v=1794380770 https://www.drarsy.com/fr/blogs/news/ruxolitinib-71-child-adolescent-phase1-pk-study 2026-11-10T23:06:12-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-71-child-adolescent-phase1-pk-study.jpg?v=1794380772 https://www.drarsy.com/fr/blogs/news/ruxolitinib-cream-phase2-3-population-pk-analysis 2026-11-10T23:06:14-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-cream-phase2-3-population-pk-analysis.jpg?v=1794380774 https://www.drarsy.com/fr/blogs/news/ruxolitinib-cream-anatomic-regions-1208-pooled-analysis 2026-11-10T23:06:16-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-cream-anatomic-regions-1208-pooled-analysis.jpg?v=1794380776 https://www.drarsy.com/fr/blogs/news/ruxolitinib-29-child-maximum-use-52-week-study 2026-11-10T23:06:18-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-29-child-maximum-use-52-week-study.jpg?v=1794380778 https://www.drarsy.com/fr/blogs/news/ruxolitinib-307-adult-itch-quality-life-phase2-analysis 2026-11-10T23:06:20-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-307-adult-itch-quality-life-phase2-analysis.jpg?v=1794380780 https://www.drarsy.com/fr/blogs/news/ruxolitinib-428-patient-as-needed-disease-control-analysis 2026-11-10T23:06:22-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-428-patient-as-needed-disease-control-analysis.jpg?v=1794380782 https://www.drarsy.com/fr/blogs/news/ruxolitinib-1031-patient-52-week-long-term-safety-analysis 2026-11-10T23:06:24-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-1031-patient-52-week-long-term-safety-analysis.jpg?v=1794380784 https://www.drarsy.com/fr/blogs/news/ruxolitinib-78-higher-severity-threshold-posthoc-analysis 2026-11-10T23:06:33-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-78-higher-severity-threshold-posthoc-analysis.jpg?v=1794380793 https://www.drarsy.com/fr/blogs/news/ruxolitinib-307-adult-dose-ranging-triamcinolone-reference-trial 2026-11-10T23:06:35-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-307-adult-dose-ranging-triamcinolone-reference-trial.jpg?v=1794380795 https://www.drarsy.com/fr/blogs/news/ruxolitinib-1249-patient-prior-treatment-posthoc-analysis 2026-11-10T23:06:37-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-1249-patient-prior-treatment-posthoc-analysis.jpg?v=1794380797 https://www.drarsy.com/fr/blogs/news/topical-jak-inhibitors-10-rct-safety-network-meta-analysis 2026-11-10T23:06:39-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/topical-jak-inhibitors-10-rct-safety-network-meta-analysis.jpg?v=1794380799 https://www.drarsy.com/fr/blogs/news/ruxolitinib-cream-five-rct-1912-patient-meta-analysis 2026-11-10T23:06:41-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-cream-five-rct-1912-patient-meta-analysis.jpg?v=1794380801 https://www.drarsy.com/fr/blogs/news/pediatric-topical-jak-eight-study-541-patient-review 2026-11-10T23:06:43-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pediatric-topical-jak-eight-study-541-patient-review.jpg?v=1794380803 https://www.drarsy.com/fr/blogs/news/pediatric-nonsteroidal-topicals-network-meta-analysis-2026 2026-11-10T23:06:46-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/pediatric-nonsteroidal-topicals-network-meta-analysis-2026.jpg?v=1794380805 https://www.drarsy.com/fr/blogs/news/topical-anti-inflammatory-291-trial-cochrane-network-analysis 2026-11-10T23:06:47-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/topical-anti-inflammatory-291-trial-cochrane-network-analysis.jpg?v=1794380807 https://www.drarsy.com/fr/blogs/news/crisaborole-delgocitinib-ruxolitinib-17-study-meta-analysis 2026-11-10T23:06:49-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/crisaborole-delgocitinib-ruxolitinib-17-study-meta-analysis.jpg?v=1794380809 https://www.drarsy.com/fr/blogs/news/ruxolitinib-vs-systemic-12-study-network-meta-analysis 2026-11-10T23:06:51-08:00 weekly https://cdn.shopify.com/s/files/1/0755/4701/7491/articles/ruxolitinib-vs-systemic-12-study-network-meta-analysis.jpg?v=1794380811